Conclusions: We have experimentally demonstrated a new target of neuroprotection in PD conditions - apoptosis of dopamine-producing neurons and substantiated modulators of this process - drugs for combined therapy with amantadine (melatonin, cerebrocurin, pronoran, and gliatilin) as promising drugs for PD treatment.
Tyshchenko et al. (Thu,) studied this question.